Evidence map›Paper›PMID 42523604›Full record

ArticlemedRxiv : the preprint server for health sciences2026

PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups.

Hagai Levi, Qin Wang, Manjeet K Bolla, Joe Dennis, Irene L Andrulis, Natalia Antonenkova, Chun Hang Au, Annelie Augustinsson, Laura E Beane Freeman, Sabine Behrens and 92 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

102 authors.

Hagai LeviBlavatnik School of Computer Science and AI, Tel Aviv University, Tel Aviv, Israel.
Qin WangCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK, CB1 8RN, 2 Worts' Causeway.
Manjeet K BollaCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK, CB1 8RN, 2 Worts' Causeway.
Joe DennisCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK, CB1 8RN, 2 Worts' Causeway.
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada, M5G 1X5, 600 University Avenue.
Natalia AntonenkovaN.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus, 223040, Settlement of Lesnoy-2.
Chun Hang AuMolecular Pathology Division, Department of Pathology, Hong Kong Sanatorium and Hospital, Hong Kong, 2 Village Rd.
Annelie AugustinssonOncology, Department of Clinical Sciences in Lund, Lund University, Lund, Sweden, 221 85, Barngatan 4, Skånes universitetssjukhus.
Laura E Beane FreemanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, 20850, 9609 Medical Center Dr.
Sabine BehrensDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany, 69120, Im Neuenheimer Feld 280.
Marina BermishevaInstitute of Biochemistry and Genetics-Subdivision of the Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia, 450054, 71 prosp. Oktyabrya.
Clara BodelonDepartment of Population Science, American Cancer Society, Atlanta, GA, USA, 30303, 250 Williams Street NW.
Natalia V BogdanovaDepartment of Radiation Oncology, Hannover Medical School, Hannover, Germany, 30625, Carl-Neuberg-Straße 1.
Stig E BojesenCopenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark, 2730, Herlev Ringvej 75.
Hermann BrennerCancer Prevention Graduate School, German Cancer Research Center (DKFZ), Heidelberg, Germany, 69120, Im Neuenheimer Feld 280.
Ian W BrockDivision of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK, S10 2TN, Western Bank.
Thomas BrüningInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany, 44789, Bürkle-de-la-Camp-Platz 1.
Helen ByersNorth West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK, M13 9WL, Oxford Road.
Nicola J CampDepartment of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA, 84112, 2000 Circle of Hope.
Jose E CastelaoOncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur (IIS-GS), SERGAS, Vigo, Spain, 36312, Estrada Clara Campoamor n° 341.
Ji-Yeob ChoiDepartment of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea, 03080, 103 Daehak-ro, Jongno-gu Seoul.
Wendy K ChungBoston Children's Hospital, Harvard Medical School, Boston, MA, USA.
NBCS Collaborators
Sarah V ColonnaDepartment of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA, 84112, 2000 Circle of Hope.
Fergus J CouchDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA, 55905, 200 First St. SW.
Kamila CzeneDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, 171 65, Karolinska Univ Hospital.
Mary B DalyDepartment of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA, 19111, 333 Cottman Ave.
Peter DevileeDepartment of Pathology, Leiden University Medical Center, Leiden, the Netherlands, 2333 ZA, Albinusdreef 2.
Thilo DörkGynaecology Research Unit, Hannover Medical School, Hannover, Germany, 30625, Carl-Neuberg-Straße 1.
A Heather EliassenChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, 02115, 181 Longwood Avenue, 3rd Floor.
Mikael ErikssonDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, 171 65, Karolinska Univ Hospital.
D Gareth EvansDivision of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK, M13 9WL, Oxford Road.
Peter A FaschingDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany, 91054, Maximiliansplatz 2.
Kierstin FawDepartment of Population Science, American Cancer Society, Atlanta, GA, USA, 30303, 250 Williams Street NW.
Manuela Gago-DominguezCancer Genetics and Epidemiology Group IDIS, Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain, 15706, Travesía da Choupana S/N.
Montserrat García-ClosasDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK, SW7 3RP.
Christopher A HaimanDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA, 90033, 1975 Zonal Ave.
Ute HamannMolecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany, 69120, Im Neuenheimer Feld 580.
Mikael HartmanSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore, 117549, 21 Lower Kent Ridge Rd.
Vikki HoDépartement de médicine sociale et préventive, Université de Montréal, Montréal, Québec, Canada, H2X 0A9, Tour Saint-Antoine, 850 rue Saint-Denis, 2e étage, bureau S02.434.
Peh Joo HoSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore, 117549, 21 Lower Kent Ridge Rd.
Maartje J HooningDepartment of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands, 3015 GD, Dr. Molewaterplein 40, P.O. Box 2040, 3000 CA.
Reiner HoppeDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany, 70376, Auerbachstr. 112.
Sacha J HowellDivision of Cancer Sciences, University of Manchester, Manchester, UK, M13 9PL.
ABCTB Investigators
SGBCC Investigators
Hidemi ItoDivision of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya, Japan, 464-8681, 1-1 Kanokoden, Chikusa-ku.
Motoki IwasakiDivision of Epidemiology, National Cancer Center Institute for Cancer Control, Tokyo, Japan, 104-0045, 5-1-1 Tsukiji, Chuo-ku.
Anna JakubowskaDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland, 71-252, Unii Lubelskiej 1.
Helena JernströmOncology, Department of Clinical Sciences in Lund, Lund University, Lund, Sweden, 221 85, Barngatan 4, Skånes universitetssjukhus.
Vijai JosephClinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 10065, 1275 York Avenue.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany, 69120, Im Neuenheimer Feld 280.
Daehee KangDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea, 03080, 103 Daehak-ro, Jongno-gu Seoul.
Elza K KhusnutdinovaInstitute of Biochemistry and Genetics-Subdivision of the Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia, 450054, 71 prosp. Oktyabrya.
Sanja KiprijanovskaResearch Centre for Genetic Engineering and Biotechnology "Georgi D. Efremov", Macedonian Academy of Sciences and Arts, Skopje, Republic of North Macedonia, 1000, Boulevard Krste Petkov Misirkov.
Stella KoutrosDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, 20850, 9609 Medical Center Dr.
Vessela N KristensenDepartment of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway, 0379, Ullernchausseen 70.
Allison W KurianDepartment of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA, 94304, 780 Welch Road, Suite CJ250C.
Ava KwongHong Kong Hereditary Breast Cancer Family Registry, Hong Kong, 18 A Kung Ngam Village Road.
Diether LambrechtsLaboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium, 3000, Oude Markt 13.
Nicole L LarsonDepartment of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA, 55905, 200 First Street SW, Harwick 6.
Loic Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA, 96813, 701 Ilalo St.
Shuai LiCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia, 3010, 207 Bouverie Street.
Jingmei LiHuman Genetics Division, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore, 138672, 60 Biopolis St.
Artitaya LophatananonDivision of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK, M13 9PL, Oxford Road.
Arto MannermaaTranslational Cancer Research Area, University of Eastern Finland, Kuopio, Finland, 70210, Yliopistonranta 1.
Keitaro MatsuoDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan, 464-8681, 1-1 Kanokoden, Chikusa-ku.
Whitney MaxwellHuntsman Cancer Institute, Salt Lake City, UT, USA, 84112, 2000 Circle of Hope.
Kenneth MuirDivision of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK, M13 9PL, Oxford Road.
Ines NevelsteenLeuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium, 3000, Oude Markt 13.
Nadia ObiInstitute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 20246, Martinistraße 52.
Katie M O'BrienEpidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA, 27709, 111 T.W. Alexander Drive.
Kenneth OffitClinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 10065, 1275 York Avenue.
Penelope D OttewellDivision of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK, S10 2TN, Western Bank.
Alpa V PatelDepartment of Population Science, American Cancer Society, Atlanta, GA, USA, 30303, 250 Williams Street NW.
Paolo PeterlongoLaboratory of Medical Genetics, Cytogenetics and Molecular Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Dijana Plaseska-KaranfilskaResearch Centre for Genetic Engineering and Biotechnology "Georgi D. Efremov", Macedonian Academy of Sciences and Arts, Skopje, Republic of North Macedonia, 1000, Boulevard Krste Petkov Misirkov.
Karolina PrajzendancDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland, 71-252, Unii Lubelskiej 1.
Paolo RadiceUnit of "Predictive Medicine: Molecular Bases of Genetic Risk", Department of Experimental Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy, 20133, Via Giacomo Venezian 1.
Dhanya RamachandranGynaecology Research Unit, Hannover Medical School, Hannover, Germany, 30625, Carl-Neuberg-Straße 1.
Muhammad U RashidMolecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany, 69120, Im Neuenheimer Feld 580.
Atocha RomeroMedical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain, 28222, Calle Manuel de Falla, 1.
Emmanouil SaloustrosDivision of Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece, 411 10, Mezourlo.
Dale P SandlerEpidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA, 27709, 111 T.W. Alexander Drive.
Ben SchöttkerDivision of Clinical Epidemiology of Early Cancer Detection, German Cancer Research Center (DKFZ), Heidelberg, Germany, 69120, Im Neuenheimer Feld 280.
Jacques SimardGenomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, Québec, Canada, G1V 4G2, 2705 Laurier Boulevard.
Melissa C SoutheyPrecision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia, 3168, 246 Clayton Road.
Jennifer StoneGenetic Epidemiology Group, School of Population and Global Health, University of Western Australia, Perth, Western Australia, Australia, 6000, 35 Stirling Hwy.
Pierre-Emmanuel SugierTeam "Exposome and Heredity", CESP, Gustave Roussy, INSERM, University Paris-Saclay, UVSQ, Villejuif, France, 94805, 39 rue Camille Desmoulins.
Jack A TaylorEpidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA, 27709, 111 T.W. Alexander Drive.
Lauren R TerasDepartment of Population Science, American Cancer Society, Atlanta, GA, USA, 30303, 250 Williams Street NW.
Thérèse TruongTeam "Exposome and Heredity", CESP, Gustave Roussy, INSERM, University Paris-Saclay, UVSQ, Villejuif, France, 94805, 39 rue Camille Desmoulins.
Clarice R WeinbergBiostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA, 27709, 111 T.W. Alexander Drive.
Siddhartha YadavDepartment of Oncology, Mayo Clinic, Rochester, MN, USA, 55905, 200 First Street SW.
Taiki YamajiDivision of Epidemiology, National Cancer Center Institute for Cancer Control, Tokyo, Japan, 104-0045, 5-1-1 Tsukiji, Chuo-ku.
Wei ZhengDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA, 37232, 1161 21st Ave S # D3300.
Alison M DunningCentre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK, CB1 8RN, 2 Worts' Causeway.
Nasim MavaddatCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK, CB1 8RN, 2 Worts' Causeway.
Douglas F EastonCentre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK, CB1 8RN, 2 Worts' Causeway.
Kyriaki MichailidouDepartment of Biostatistics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus, 2371, 6 Iroon Avenue, 2371 Ayios Dometios, Nicosia, P.O.Box 23462, 1683, Nicosia, Cyprus.
Ran ElkonGray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Ron ShamirBlavatnik School of Computer Science and AI, Tel Aviv University, Tel Aviv, Israel.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, TAMIMI, RULLA M · 2000 to 2019
$77.8M
Tissue Procurement & PathologyP50CA058223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BENJAMIN CARLISLE CALHOUN · 1992 to 2026
$59.3M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
Understanding Population Differences in Cancer: The MEC StudyU01CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HAIMAN, CHRISTOPHER ALAN, LE MARCHAND, LOIC · 2015 to 2025
$37.4M
CALIFORNIA TEACHERS STUDYR01CA077398 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERNSTEIN, LESLIE · 1998 to 2014
$29.7M
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSR01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2001 to 2005
$23.2M
Multiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Oil and Gas as Drivers of Climate Change and Health: Developing unique resources to investigate multi-level and diverse effects of exposure to oil and gas wellsU01CA199277 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI LACEY, JAMES V, MARTINEZ, MARIA ELENA · 2015 to 2024
$20.7M
Intramural NIH HHS Z01 CP010119Intramural NIH HHS Z01 ES044005Intramural NIH HHS Z01 ES049030Intramural NIH HHS Z01 ES049033NCCDPHP CDC HHS NU58DP006344NCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800016CNCI NIH HHS HHSN261201800016INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032INCI NIH HHS K07 CA092044NCI NIH HHS P01 CA087969NCI NIH HHS P30 CA023100NCI NIH HHS P30 CA033572NCI NIH HHS P30 CA068485NCI NIH HHS P50 CA058223NCI NIH HHS P50 CA116201NCI NIH HHS R01 CA054281NCI NIH HHS R01 CA058860NCI NIH HHS R01 CA063464NCI NIH HHS R01 CA064277NCI NIH HHS R01 CA077398NCI NIH HHS R01 CA100374NCI NIH HHS R01 CA116167NCI NIH HHS R01 CA128978NCI NIH HHS R01 CA132839NCI NIH HHS R01 CA148667NCI NIH HHS R01 CA163353NCI NIH HHS R01 CA176785NCI NIH HHS R01 CA192393NCI NIH HHS R35 CA253187NCI NIH HHS R37 CA054281NCI NIH HHS R37 CA070867NCI NIH HHS U01 CA058860NCI NIH HHS U01 CA063464NCI NIH HHS U01 CA098758NCI NIH HHS U01 CA164920NCI NIH HHS U01 CA164973NCI NIH HHS U01 CA179715NCI NIH HHS U01 CA199277NCI NIH HHS U19 CA148065NCI NIH HHS U19 CA148112NCI NIH HHS U19 CA148537NCI NIH HHS U54 CA156733NCI NIH HHS UM1 CA164917NCI NIH HHS UM1 CA164920NCI NIH HHS UM1 CA164973NCI NIH HHS UM1 CA176726NCI NIH HHS UM1 CA186107
6 · The paper itself

Abstract

Polygenic risk scores (PRSs), which quantify inherited susceptibility to complex traits and diseases, have emerged as valuable tools for risk stratification and precision medicine. Despite their promise, PRS developed on European cohorts often demonstrate substantially reduced predictive accuracy in non-European populations, due to differences in genetic architecture. The disproportionate representation of European ancestry cohorts in genome-wide association studies (GWAS) leads to inequitable deployment of PRS technologies across diverse populations. Here, we introduce PRANA (Polygenic Risk Adaptation via Neural-network Architecture), a deep learning framework that adapts an existing PRS developed on one population to other ancestries. Unlike methods that require large-scale GWAS in the target population, PRANA leverages pre-trained PRS models derived from European cohorts and adapts them using modestly sized cohorts from the target population. We evaluated PRANA on seven complex traits in South Asian, East Asian and Ashkenazi Jewish populations, as well as in selected smaller East Asian subpopulations where the scarcity of training data poses a particular challenge. PRANA mostly improved predictive performance of the baseline PRS models by 5%-20% in terms of effect size (β) and Nagelkerke's R

Identifiers

PMID42523604
PMCPMC13405543

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.